Animal models of GWAS-identified type 2 diabetes genes

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Da Silva Xavier, Gabriela ^a   Bellomo, Elisa A ^a   McGinty, James A ^a   French, Paul M ^a   Rutter, Guy A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; SLC30A8 PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; ZINC TRANSPORTER;

ANIMAL MODEL; EXPERIMENTAL ANIMAL WELFARE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH THROUGHPUT SCREENING; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE; WEIGHT REDUCTION; ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84878153315     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/906590     Document Type: Review

References (139)

1. Diabetes UK, Diabetes in the UK 2012: key statistics on diabetes. 2013
2. Hu F. B., Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011 34 1249 1257
3. Hu F. B., Li T. Y., Colditz G. A., Willett W. C., Manson J. E., Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. Journal of the American Medical Association 2003 289 14 1785 1791 2-s2.0-0037502809 10.1001/jama.289.14.1785 (Pubitemid 37430247)
4. Knowler W. C., Barrett-Connor E., Fowler S. E., Hamman R. F., Lachin J. M., Walker E. A., Nathan D. M., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002 346 6 393 403 2-s2.0-0037034257 10.1056/NEJMoa012512 (Pubitemid 34437694)
5. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A. D., Vijay V., The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006 49 2 289 297 2-s2.0-31844452061 10.1007/s00125-005-0097-z (Pubitemid 43185397)
6. Salas-Salvadó J., Bulló M., Babio N., Martínez- González M. Á., Ibarrola-Jurado N., Basora J., Estruch R., Covas M. I., Corella D., Arós F., Ruiz-Gutiérrez V., Ros E., Reduction in the incidence of type 2 diabetes with the mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011 34 1 14 19 2-s2.0-78651350459 10.2337/dc10-1288
7. Tuomilehto J., Lindström J., Eriksson J. G., Valle T. T., Hamäläinen H., Ianne-Parikka P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001 344 18 1343 1350 2-s2.0-0035799806 10.1056/NEJM200105033441801 (Pubitemid 32378388)
8. Van Dam R. M., The epidemiology of lifestyle and risk for type 2 diabetes. European Journal of Epidemiology 2003 18 12 1115 1125 2-s2.0-0345827813 10.1023/B:EJEP.0000006612.70245.24 (Pubitemid 38083957)
9. Yach D., Stuckler D., Brownell K. D., Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine 2006 12 62 66 2-s2.0-33644828471 10.1038/nm0306-367a (Pubitemid 43355088)
10. Wilson P. W. F., Meigs J. B., Sullivan L., Fox C. S., Nathan D. M., D'Agostino R. B. Sr., Prediction of incident diabetes mellitus in middle-aged adults: the framingham offspring study. Archives of Internal Medicine 2007 167 10 1068 1074 2-s2.0-34249654186 10.1001/archinte.167.10.1068 (Pubitemid 46835795)
11. Rana J. S., Li T. Y., Manson J. E., Hu F. B., Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 2007 30 1 53 58 2-s2.0-33846075221 10.2337/dc06-1456 (Pubitemid 46061292)
12. Malik V. S., Popkin B. M., Bray G. A., Després J. P., Willett W. C., Hu F. B., Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010 33 11 2477 2483 2-s2.0-78650920491 10.2337/dc10-1079
13. Risérus U., Willett W. C., Hu F. B., Dietary fats and prevention of type 2 diabetes. Progress in Lipid Research 2009 48 1 44 51 2-s2.0-57649195613 10.1016/j.plipres.2008.10.002
14. Barclay A. W., Petocz P., McMillan-Price J., Flood V. M., Prvan T., Mitchell P., Brand-Miller J. C., Glycemic index, glycemic load, and chronic disease risk-a metaanalysis of observational studies. American Journal of Clinical Nutrition 2008 87 3 627 637 2-s2.0-40549125281 (Pubitemid 351364544)
15. Christakis N. A., Fowler J. H., The spread of obesity in a large social network over 32 years. New England Journal of Medicine 2007 357 4 370 379 2-s2.0-34547170053 10.1056/NEJMsa066082 (Pubitemid 47124137)
16. Willi C., Bodenmann P., Ghali W. A., Faris P. D., Cornuz J., Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2007 298 22 2654 2664 2-s2.0-37149034177 10.1001/jama.298.22.2654 (Pubitemid 350254957)
17. Burdge G. C., Lillycrop K. A., Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annual Review of Nutrition 2010 30 315 339 2-s2.0-77955627637 10.1146/annurev.nutr.012809.104751
18. Poulsen P., Ohm Kyvik K., Vaag A., Beck-Nielsen H., Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 1999 42 2 139 145 2-s2.0-0032953097 10.1007/s001250051131 (Pubitemid 29064234)
19. Owen K., Hattersley A. T., Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Practice and Research 2001 15 3 309 323 2-s2.0-0034809513 10.1053/beem.2001.0148 (Pubitemid 32916264)
20. Farooqi I. S., O'Rahilly S., Genetics of obesity in humans. Endocrine Reviews 2006 27 7 710 718 2-s2.0-33845567553 10.1210/er.2006-0040 (Pubitemid 44936054)
21. Risch N., Merikangas K., The future of genetic studies of complex human diseases. Science 1996 273 5281 1516 1517 2-s2.0-0029741063 (Pubitemid 26301653)
22. Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M. C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S., The common PPAR γ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 2000 26 1 76 80 2-s2.0-0033624575 10.1038/79216
23. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). Journal of Biological Chemistry 1995 270 22 12953 12956 2-s2.0-0029016829 10.1074/jbc.270.22.12953
24. Gloyn A. L., Weedon M. N., Owen K. R., Turner M. J., Knight B. A., Hitman G., Walker M., Levy J. C., Sampson M., Halford S., McCarthy M. I., Hattersley A. T., Frayling T. M., Large-scale association studies of variants in genes encoding the pancreatic β -cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003 52 2 568 572 2-s2.0-0037317981 10.2337/diabetes.52.2.568 (Pubitemid 36173218)
25. Grant S. F. A., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K. P., Walters G. B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R. L., Reilly M. P., Rader D. J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J. R., Kong A., Stefansson K., Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 2006 38 3 320 323 2-s2.0-32544451924 10.1038/ng1732
26. Saxena R., Voight B. F., Lyssenko V., Burtt N. P., De Bakker P. I. W., Chen H., Roix J. J., Kathiresan S., Hirschhorn J. N., Daly M. J., Hughes T. E., Groop L., Altshuler D., Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007 316 5829 1331 1336 2-s2.0-34249888775 10.1126/science.1142358 (Pubitemid 46871653)
27. Scott L. J., Mohlke K. L., Bonnycastle L. L., Willer C. J., Li Y., Duren W. L., Erdos M. R., Stringham H. M., Chines P. S., Jackson A. U., Prokunina-Olsson L., Ding C. J., Swift A. J., Narisu, Hu T., Pruim R., Xiao R., Li X. Y., Conneely K. N., Riebow N. L., Sprau A. G., Tong M., White P. P., Hetrick K. N., Barnhart M. W., Bark C. W., Goldstein J. L., Watkins L., Xiang F., Saramies J., Buchanan T. A., Watanabe R. M., Valle T. T., Kinnunen L., Abecasis G. R., Pugh E. W., Doheny K. F., Bergman R. N., Tuomilehto J., Collins F. S., Boehnke M., A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science 2007 316 5829 1341 1345 2-s2.0-34249885875 10.1126/science.1142382 (Pubitemid 46871655)
28. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T. J., Montpetit A., Pshezhetsky A. V., Prentki M., Posner B. I., Balding D. J., Meyre D., Polychronakos C., Froguel P., A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007 445 7130 881 885 2-s2.0-33847176604 10.1038/nature05616
29. Zeggini E., Weedon M. N., Lindgren C. M., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007 316 1336 1341 (Pubitemid 46871654)
30. Cho Y. S., Chen C. H., Hu C., Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nature Genetics 2012 44 67 72
31. Dupuis J., Langenberg C., Prokopenko I., New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 2010 42 105 116
32. Kooner J. S., Saleheen D., Sim X., Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nature Genetics 2011 43 984 989
33. Palmer N. D., McDonough C. W., Hicks P. J., A genome-wide association search for type 2 diabetes genes in African Americans. PLoS ONE 2012 7 e29202
34. Voight B. F., Scott L. J., Steinthorsdottir V., Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics 2010 42 579 589
35. Morris A. P., Voight B. F., Teslovich T. M., Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics 2012 44 981 990
36. Cornelis M. C., Qi L., Zhang C., Kraft P., Manson J., Cai T., Hunter D. J., Hu F. B., Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Annals of Internal Medicine 2009 150 8 541 550 2-s2.0-65349192772
37. De Miguel-Yanes J. M., Shrader P., Pencina M. J., Fox C. S., Manning A. K., Grant R. W., Dupuis J., Florez J. C., D'Agostino R. B., Cupples L. A., Meigs J. B., Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 2011 34 1 121 125 2-s2.0-79951715822 10.2337/dc10-1265
38. Florez J. C., Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008 51 7 1100 1110 2-s2.0-44749085712 10.1007/s00125-008-1025-9
39. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., Balkau B., Charpentier G., Pattou F., Stetsyuk V., Scharfmann R., Staels B., Frühbeck G., Froguel P., Transcription factor TCF7L2 genetic study in the French population: expression in human β -cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006 55 10 2903 2908 2-s2.0-33750889376 10.2337/db06-0474 (Pubitemid 44923694)
40. Maeda S., Osawa N., Hayashi T., Tsukada S., Kobayashi M., Kikkawa R., Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population. Kidney International 2007 72 106, supplement S43 S48 2-s2.0-34547454286 10.1038/sj.ki.5002385 (Pubitemid 47172560)
41. Meigs J. B., Rutter M. K., Sullivan L. M., Fox C. S., D'Agostino R. B., Wilson P. W. F., Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007 30 5 1219 1225 2-s2.0-34247603049 10.2337/dc06-2484 (Pubitemid 46684651)
42. Herder C., Rathmann W., Strassburger K., Finner H., Grallert H., Huth C., Meisinger C., Gieger C., Martin S., Giani G., Scherbaum W. A., Wichmann H. E., Illig T., Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Hormone and Metabolic Research 2008 40 10 722 726 2-s2.0-54049110420 10.1055/s-2008-1078730
43. Sanghera D. K., Ortega L., Han S., Singh J., Ralhan S. K., Wander G. S., Mehra N. K., Mulvihill J. J., Ferrell R. E., Nath S. K., Kamboh M. I., Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Medical Genetics 2008 9, article 59 2-s2.0-47749128415 10.1186/1471-2350-9-59
44. Cho Y. M., Kim T. H., Lim S., Choi S. H., Shin H. D., Lee H. K., Park K. S., Jang H. C., Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 2009 52 2 253 261 2-s2.0-58149464121 10.1007/s00125-008-1196-4
45. Tabara Y., Osawa H., Kawamoto R., Onuma H., Shimizu I., Miki T., Kohara K., Makino H., Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009 58 2 493 498 2-s2.0-63249118012 10.2337/db07-1785
46. Marquezine G. F., Pereira A. C., Sousa A. G. P., Mill J. G., Hueb W. A., Krieger J. E., TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population. BMC Medical Genetics 2008 9, article 106 2-s2.0-59449084138 10.1186/1471-2350-9-106
47. Ezzidi I., Mtiraoui N., Cauchi S., Vaillant E., Dechaume A., Chaieb M., Kacem M., Almawi W. Y., Froguel P., Mahjoub T., Vaxillaire M., Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. BMC Medical Genetics 2009 10, article 33 2-s2.0-65549152213 10.1186/1471-2350-10-33
48. Takeuchi F., Serizawa M., Yamamoto K., Fujisawa T., Nakashima E., Ohnaka K., Ikegami H., Sugiyama T., Katsuya T., Miyagishi M., Nakashima N., Nawata H., Nakamura J., Kono S., Takayanagi R., Kato N., Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009 58 7 1690 1699 2-s2.0-67650248695 10.2337/db08-1494
49. Ereqat S., Nasereddin A., Cauchi S., Azmi K., Abdeen Z., Amin R., Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in the Palestinian population. Acta Diabetologica 2010 47 1, supplement S195 S198 2-s2.0-78751597996 10.1007/s00592-009-0161-0
50. Wen J., Rönn T., Olsson A., Yang Z., Lu B., Du Y., Groop L., Ling C., Hu R., Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS ONE 2010 5 2 2-s2.0-77949346987 10.1371/journal.pone.0009153 e9153
51. Chauhan G., Spurgeon C. J., Tabassum R., Bhaskar S., Kulkarni S. R., Mahajan A., Chavali S., Kumar M. V. K., Prakash S., Dwivedi O. P., Ghosh S., Yajnik C. S., Tandon N., Bharadwaj D., Chandak G. R., Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes 2010 59 8 2068 2074 2-s2.0-77955411524 10.2337/db09-1386
52. Karns R., Zhang G., Jeran N., Havas-Augustin D., Missoni S., Niu W., Indugula S. R., Sun G., Durakovic Z., Narancic N. S., Rudan P., Chakraborty R., Deka R., Replication of genetic variants from genome-wide association studies with metabolic traits in an island population of the Adriatic coast of Croatia. European Journal of Human Genetics 2011 19 3 341 346 2-s2.0-79951812460 10.1038/ejhg.2010.178
53. Ramos E., Chen G., Shriner D., Doumatey A., Gerry N. P., Herbert A., Huang H., Zhou J., Christman M. F., Adeyemo A., Rotimi C., Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans. Diabetologia 2011 54 4 783 788 2-s2.0-79953822887 10.1007/s00125-010-2002-7
54. Rees S. D., Hydrie M. Z., Shera A. S., Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia 2011 54 1368 1374
55. Saxena R., Elbers C. C., Guo Y., Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. American Journal of Human Genetics 2012 90 410 425
56. Cauchi S., Ezzidi I., El A. Y., European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes & Metabolism 2012 38 316 323
57. Mtiraoui N., Turki A., Nemr R., Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARgamma, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes & Metabolism 2012 38 444 449
58. Turki A., Al-Zaben G. S., Mtiraoui N., Marmmuoch H., Mahjoub T., Almawi W. Y., Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects. Gene 2013 513 244 248
59. Long J., Edwards T., Signorello L. B., Evaluation of genome-wide association study-identified type 2 diabetes loci in African Americans. American Journal of Epidemiology 2012 176 995 1001
60. Helgason A., Pálsson S., Thorleifsson G., Grant S. F. A., Emilsson V., Gunnarsdottir S., Adeyemo A., Chen Y., Chen G., Reynisdottir I., Benediktsson R., Hinney A., Hansen T., Andersen G., Borch-Johnsen K., Jorgensen T., Schäfer H., Faruque M., Doumatey A., Zhou J., Wilensky R. L., Reilly M. P., Rader D. J., Bagger Y., Christiansen C., Sigurdsson G., Hebebrand J., Pedersen O., Thorsteinsdottir U., Gulcher J. R., Kong A., Rotimi C., Stefánsson K., Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 2007 39 2 218 225 2-s2.0-33846596193 10.1038/ng1960 (Pubitemid 46184353)
61. Florez J. C., Jablonski K. A., Bayley N., Pollin T. I., De Bakker P. I. W., Shuldiner A. R., Knowler W. C., Nathan D. M., Altshuler D., TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. New England Journal of Medicine 2006 355 3 241 250 2-s2.0-33746075560 10.1056/NEJMoa062418 (Pubitemid 44079339)
62. Wang J., Kuusisto J., Vänttinen M., Kuulasmaa T., Lindström J., Tuomilehto J., Uusitupa M., Laakso M., Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007 50 6 1192 1200 2-s2.0-34247855851 10.1007/s00125-007-0656-6 (Pubitemid 46701561)
63. Dabelea D., Dolan L. M., D'Agostino R., Hernandez A. M., McAteer J. B., Hamman R. F., Mayer-Davis E. J., Marcovina S., Lawrence J. M., Pihoker C., Florez J. C., Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia 2011 54 3 535 539 2-s2.0-79953759608 10.1007/s00125-010-1982-7
64. Raitakari O. T., Rönnemaa T., Huupponen R., Viikari L., Fan M., Marniemi J., Hutri-Kähönen N., Viikari J. S., Lehtimäki T., Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults. The Cardiovascular Risk in Young Finns Study. Diabetes Care 2007 30 2299 2301 2-s2.0-37149053248 10.2337/dc07-er12b
65. Jin T., Liu L., The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Molecular Endocrinology 2008 22 11 2383 2392 2-s2.0-55049106032 10.1210/me.2008-0135
66. Reya T., Clevers H., Wnt signalling in stem cells and cancer. Nature 2005 434 7035 843 850 2-s2.0-17244376814 10.1038/nature03319 (Pubitemid 40558990)
67. Rulifson I. C., Karnik S. K., Heiser P. W., Ten Berge D., Chen H., Gu X., Taketo M. M., Nusse R., Hebrok M., Kim S. K., Wnt signaling regulates pancreatic β cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 2007 104 15 6247 6252 2-s2.0-34547516561 10.1073/pnas.0701509104 (Pubitemid 47186080)
68. Papadopoulou S., Edlund H., Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005 54 10 2844 2851 2-s2.0-25844530871 10.2337/diabetes.54.10.2844 (Pubitemid 41401078)
69. Wells J. M., Esni F., Boivin G. P., Aronow B. J., Stuart W., Combs C., Sklenka A., Leach S. D., Lowy A. M., Wnt/ β -catenin signaling is required for development of the exocrine pancreas. BMC Developmental Biology 2007 7, article 4 2-s2.0-33846807059 10.1186/1471-213X-7-4 (Pubitemid 46201620)
70. Heiser P. W., Lau J., Taketo M. M., Herrera P. L., Hebrok M., Stabilization of β -catenin impacts pancreas growth. Development 2006 133 10 2023 2032 2-s2.0-33745084564 10.1242/dev.02366 (Pubitemid 43881267)
71. Loos R. J. F., Franks P. W., Francis R. W., Barroso I., Gribble F. M., Savage D. B., Ong K. K., O'Rahilly S., Wareham N. J., TCF7L2 polymorphisms modulate proinsulin levels and β -cell function in a British europid population. Diabetes 2007 56 7 1943 1947 2-s2.0-34347393853 10.2337/db07-0055 (Pubitemid 47025464)
72. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Almgren P., Sjögren M., Ling C., Eriksson K. F., Lethagen Å.. L., Mancarella R., Berglund G., Tuomi T., Nilsson P., Del Prato S., Groop L., Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation 2007 117 8 2155 2163 2-s2.0-34547702501 10.1172/JCI30706 (Pubitemid 47219560)
73. Villareal D. T., Robertson H., Bell G. I., Patterson B. W., Tran H., Wice B., Polonsky K. S., TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 2010 59 2 479 485 2-s2.0-77449099615 10.2337/db09-1169
74. Shu L., Matveyenko A. V., Kerr-Conte J., Cho J. H., McIntosh C. H. S., Maedler K., Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Human Molecular Genetics 2009 18 13 2388 2399 2-s2.0-67249096093 10.1093/hmg/ddp178
75. Shu L., Sauter N. S., Schulthess F. T., Matveyenko A. V., Oberholzer J., Maedler K., Transcription factor 7-like 2 regulates β -cell survival and function in human pancreatic islets. Diabetes 2008 57 3 645 653 2-s2.0-40949141938 10.2337/db07-0847
76. Da Silva Xavier G., Loder M. K., McDonald A., Tarasov A. I., Carzaniga R., Kronenberger K., Barg S., Rutter G. A., TCF7L2 regulates late events in insulin secretion from pancreatic islet β -cells. Diabetes 2009 58 4 894 905 2-s2.0-64649105053 10.2337/db08-1187
77. da Silva Xavier G., Mondragon A., Sun G., Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 2012 55 2667 2676
78. Prokunina-Olsson L., Welch C., Hansson O., Adhikari N., Scott L. J., Usher N., Tong M., Sprau A., Swift A., Bonnycastle L. L., Erdos M. R., He Z., Saxena R., Harmon B., Kotova O., Hoffman E. P., Altshuler D., Groop L., Boehnke M., Collins F. S., Hall J. L., Tissue-specific alternative splicing of TCF7L2. Human Molecular Genetics 2009 18 20 3795 3804 2-s2.0-70349569023 10.1093/hmg/ddp321
79. Liu Z., Habener J. F., Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. Journal of Biological Chemistry 2008 283 13 8723 8735 2-s2.0-43749120731 10.1074/jbc.M706105200
80. Slattery M. L., Folsom A. R., Wolff R., Herrick J., Caan B. J., Potter J. D., Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiology Biomarkers and Prevention 2008 17 4 978 982 2-s2.0-42149181801 10.1158/1055-9965.EPI-07-2687 (Pubitemid 351536432)
81. Saadeddin A., Babaei-Jadidi R., Spencer-Dene B., Nateri A. S., The links between transcription, β -catenin/JNK signaling, and carcinogenesis. Molecular Cancer Research 2009 7 8 1189 1196 2-s2.0-69449101810 10.1158/1541-7786.MCR-09-0027
82. Roose J., Clevers H., TCF transcription factors: molecular switches in carcinogenesis. Biochimica et Biophysica Acta 1999 1424 2-3 M23 M37 2-s2.0-0032830931 10.1016/S0304-419X(99)00026-8 (Pubitemid 29488713)
83. Korinek V., Barker N., Moerer P., Van Donselaar E., Huls G., Peters P. J., Clevers H., Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics 1998 19 4 379 383 2-s2.0-0031848068 10.1038/1270 (Pubitemid 28357912)
84. Boj S. F., van Es J. H., Huch M., Li V. S., José A., Hatzis P., Mokry M., Haegebarth A., van den Born M., Chambon P., Voshol P., Dor Y., Cuppen E., Fillat C., Clevers H., Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 2012 151 7 1595 1607
85. Savic D., Ye H., Aneas I., Park S. Y., Bell G. I., Nobrega M. A., Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Research 2011 21 1417 1425
86. Yang H., Li Q., Lee J. H., Shu Y., Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice. International Journal of Biological Sciences 2012 8 791 801
87. Barker N., Huls G., Korinek V., Clevers H., Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. American Journal of Pathology 1999 154 1 29 35 2-s2.0-0032921038 (Pubitemid 29031608)
88. Horikoshi M., Hara K., Ito C., Nagai R., Froguel P., Kadowaki T., A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia 2007 50 4 747 751 2-s2.0-33847618213 10.1007/s00125-006-0588-6 (Pubitemid 46355825)
89. Schäfer S. A., Tschritter O., Machicao F., Thamer C., Stefan N., Gallwitz B., Holst J. J., Dekker J. M., T'Hart L. M., Nijpels G., Van Haeften T. W., Häring H. U., Fritsche A., Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007 50 12 2443 2450 2-s2.0-35848942800 10.1007/s00125-007-0753-6 (Pubitemid 350060632)
90. Gu G., Dubauskaite J., Melton D. A., Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002 129 10 2447 2457 2-s2.0-0036340074 (Pubitemid 34863851)
91. Hisadome K., Smith M. A., Choudhury A. I., Claret M., Withers D. J., Ashford M. L. J., 5-HT inhibition of rat insulin 2 promoter Cre recombinase transgene and proopiomelanocortin neuron excitability in the mouse arcuate nucleus. Neuroscience 2009 159 1 83 93 2-s2.0-60349088591 10.1016/j. neuroscience.2008.12.003
92. Sun G., Tarasov A. I., McGinty J. A., French P. M., McDonald A., Leclerc I., Rutter G. A., LKB1 deletion with the RIP2.Cre transgene modifies pancreatic β -cell morphology and enhances insulin secretion in vivo. American Journal of Physiology: Endocrinology and Metabolism 2010 298 6 E1261 E1273 2-s2.0-77952587385 10.1152/ajpendo.00100.2010
93. Sun G., Reynolds R., Leclerc I., Rutter G. A., RIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis. DMM Disease Models and Mechanisms 2011 4 2 193 202 2-s2.0-79952331147 10.1242/dmm.006833
94. Shu L., Zien K., Gutjahr G., TCF7L2 promotes beta cell regeneration in human and mouse pancreas. Diabetologia 2012 55 3296 3307
95. Wicksteed B., Brissova M., Yan W., Opland D. M., Plank J. L., Reinert R. B., Dickson L. M., Tamarina N. A., Philipson L. H., Shostak A., Bernal-Mizrachi E., Elghazi L., Roe M. W., Labosky P. A., Myers M. G., Gannon M., Powers A. C., Dempsey P. J., Conditional gene targeting in mouse pancreatic β -cells: analysis of ectopic cre transgene expression in the brain. Diabetes 2010 59 12 3090 3098 2-s2.0-78049446505 10.2337/db10-0624
96. Dor Y., Brown J., Martinez O. I., Melton D. A., Adult pancreatic β -cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004 429 6987 41 46 2-s2.0-2342510386 10.1038/nature02520 (Pubitemid 38620543)
97. Nicolson T. J., Bellomo E. A., Wijesekara N., Loder M. K., Baldwin J. M., Gyulkhandanyan A. V., Koshkin V., Tarasov A. I., Carzaniga R., Kronenberger K., Taneja T. K., Da Silva Xavier G., Libert S., Froguel P., Scharfmann R., Stetsyuk V., Ravassard P., Parker H., Gribble F. M., Reimann F., Sladek R., Hughes S. J., Johnson P. R. V., Masseboeuf M., Burcelin R., Baldwin S. A., Liu M., Lara-Lemus R., Arvan P., Schuit F. C., Wheeler M. B., Chimienti F., Rutter G. A., Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009 58 9 2070 2083 2-s2.0-70349113136 10.2337/db09-0551
98. Hardy A. B., Wijesekara N., Genkin I., Effects of high-fat diet feeding on Znt8-null mice: differences between beta-cell and global knockout of Znt8. American Journal of Physiology: Endocrinology and Metabolism 2012 302 E1084 E1096
99. Lemaire K., Ravier M. A., Schraenen A., Creemers J. W. M., Van De Plas R., Granvik M., Van Lommel L., Waelkens E., Chimienti F., Rutter G. A., Gilon P., In't Veld P. A., Schuit F. C., Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proceedings of the National Academy of Sciences of the United States of America 2009 106 35 14872 14877 2-s2.0-70349280000 10.1073/pnas.0906587106
100. Pound L. D., Sarkar S. A., Benninger R. K. P., Wang Y., Suwanichkul A., Shadoan M. K., Printz R. L., Oeser J. K., Lee C. E., Piston D. W., McGuinness O. P., Hutton J. C., Powell D. R., O'Brien R. M., Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochemical Journal 2009 421 3 371 376 2-s2.0-69249226366 10.1042/BJ20090530
101. Pound L. D., Sarkar S. A., Ustione A., The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PLoS ONE 2012 7 e40972
102. Wijesekara N., Dai F. F., Hardy A. B., Giglou P. R., Bhattacharjee A., Koshkin V., Chimienti F., Gaisano H. Y., Rutter G. A., Wheeler M. B., Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 2010 53 8 1656 1668 2-s2.0-77955514154 10.1007/s00125-010-1733-9
103. Gaulton K. J., Nammo T., Pasquali L., Simon J. M., Giresi P. G., Fogarty M. P., Panhuis T. M., Mieczkowski P., Secchi A., Bosco D., Berney T., Montanya E., Mohlke K. L., Lieb J. D., Ferrer J., A map of open chromatin in human pancreatic islets. Nature Genetics 2010 42 3 255 259 2-s2.0-77649086970 10.1038/ng.530
104. Duval A., Rolland S., Tubacher E., Bui H., Thomas G., Hamelin R., The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Research 2000 60 14 3872 3879 2-s2.0-0034660872 (Pubitemid 32204580)
105. Le Bacquer O., Shu L., Marchand M., Neve B., Paroni F., Conte J. K., Pattou F., Froguel P., Maedler K., TCF7L2 splice variants have distinct effects on β -cell turnover and function. Human Molecular Genetics 2011 20 10 1906 1915 2-s2.0-79955444467 10.1093/hmg/ddr072
106. Mondal A. K., Das S. K., Baldini G., Chu W. S., Sharma N. K., Hackney O. G., Zhao J., Grant S. F. A., Elbein S. C., Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans. Journal of Clinical Endocrinology and Metabolism 2010 95 3 1450 1457 2-s2.0-77749239722 10.1210/jc.2009-2064
107. Weise A., Bruser K., Elfert S., Wallmen B., Wittel Y., Wöhrle S., Hecht A., Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/ β -catenin targets. Nucleic Acids Research 2009 38 6 1964 1981 2-s2.0-77951233751 10.1093/nar/gkp1197
108. Lichten L. A., Cousins R. J., Mammalian zinc transporters: nutritional and physiologic regulation. Annual Review of Nutrition 2009 29 153 176 10.1146/annurev-nutr-033009-083312
109. Chimienti F., Devergnas S., Favier A., Seve M., Identification and cloning of a β -cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004 53 9 2330 2337 2-s2.0-4344665860 10.2337/diabetes.53.9.2330 (Pubitemid 39145586)
110. Chimienti F., Favier A., Seve M., ZnT-8, a pancreatic beta-cell-specific zinc transporter. BioMetals 2005 18 4 313 317 2-s2.0-24744451161 10.1007/s10534-005-3687-9 (Pubitemid 41298014)
111. Emdin S. O., Dodson G. G., Cutfield J. M., Cutfield S. M., Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia 1980 19 3 174 182 2-s2.0-0018937820 (Pubitemid 10003175)
112. Rutter G. A., Think zinc: new roles for zinc in the control of insulin secretion. Islets 2010 2 1 49 50 2-s2.0-77953399221
113. Berglund E. D., Li C. Y., Poffenberger G., Ayala J. E., Fueger P. T., Willis S. E., Jewell M. M., Powers A. C., Wasserman D. H., Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 2008 57 7 1790 1799 2-s2.0-48249100979 10.2337/db07-1615
114. Hattersley A. T., Unlocking the secrets of the pancreatic β cell: man and mouse provide the key. Journal of Clinical Investigation 2004 114 3 314 316 2-s2.0-4043096481 10.1172/JCI200422506 (Pubitemid 39071601)
115. Reyon D., Tsai S. Q., Khayter C., Foden J. A., Sander J. D., Joung J. K., FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology 2012 30 460 465
116. Mussolino C., Cathomen T., TALE nucleases: tailored genome engineering made easy. Current Opinion in Biotechnology 2012 23 644 650
117. Hockemeyer D., Wang H., Kiani S., Lai C. S., Gao Q., Cassady J. P., Cost G. J., Zhang L., Santiago Y., Miller J. C., Zeitler B., Cherone J. M., Meng X., Hinkley S. J., Rebar E. J., Gregory P. D., Urnov F. D., Jaenisch R., Genetic engineering of human pluripotent cells using TALE nucleases. Nature Biotechnology 2011 29 8 731 734 2-s2.0-79960836456 10.1038/nbt.1927
118. Meigs J. B., Shrader P., Sullivan L. M., McAteer J. B., Fox C. S., Dupuis J., Manning A. K., Florez J. C., Wilson P. W. F., D'Agostino R. B., Cupples L. A., Genotype score in addition to common risk factors for prediction of type 2 diabetes. New England Journal of Medicine 2008 359 21 2208 2219 2-s2.0-56749101779 10.1056/NEJMoa0804742
119. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., Berglund G., Altshuler D., Nilsson P., Groop L., Clinical risk factors, DNA variants, and the development of type 2 diabetes. New England Journal of Medicine 2008 359 21 2220 2232 2-s2.0-55649105963 10.1056/NEJMoa0801869
120. Talmud P. J., Hingorani A. D., Cooper J. A., Marmot M. G., Brunner E. J., Kumari M., Kivimäki M., Humphries S. E., Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: whitehall II prospective cohort study. British Medical Journal 2010 340, article b4838 2-s2.0-75649134649 10.1136/bmj.b4838
121. Langothe H., Palmer C. N. A., Morris A. D., Zeggini E., Hattersley A. T., McCarthy M. I., Frayling T. M., Weedon M. N., Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008 57 11 3129 3135 2-s2.0-56349096931 10.2337/db08-0504
122. Simmons R. K., Harding A. H., Wareham N. J., Griffin S. J., Do simple questions about diet and physical activity help to identify those at risk of Type 2 diabetes? Diabetic Medicine 2007 24 8 830 835 2-s2.0-34447621398 10.1111/j.1464-5491.2007.02173.x (Pubitemid 47093046)
123. Lindström J., Tuomilehto J., The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003 26 3 725 731 2-s2.0-0042743790 10.2337/diacare.26.3.725 (Pubitemid 36929335)
124. Cornelis M. C., Qi L., Kraft P., Hu F. B., TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. American Journal of Clinical Nutrition 2009 89 4 1256 1262 2-s2.0-63649145042 10.3945/ajcn.2008.27058
125. Fisher E., Boeing H., Fritsche A., Doering F., Joost H. G., Schulze M. B., Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. British Journal of Nutrition 2009 101 4 478 481 2-s2.0-67649427368 10.1017/ S0007114508020369
126. Haupt A., Thamer C., Heni M., Ketterer C., Machann J., Schick F., Machicao F., Stefan N., Claussen C. D., Häring H. U., Fritsche A., Staiger H., Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes 2010 59 3 747 750 2-s2.0-77950344135 10.2337/db09-1050
127. Reinehr T., Friedel S., Mueller T. D., Toschke A. M., Hebebrand J., Hinney A., Evidence for an influence of TCF7L2 polymorphism rs7903146 on insulin resistance and sensitivity indices in overweight children and adolescents during a lifestyle intervention. International Journal of Obesity 2008 32 10 1521 1524 2-s2.0-53849101803 10.1038/ijo.2008.146
128. Thomas D., Gene-environment-wide association studies: emerging approaches. Nature Reviews Genetics 2010 11 4 259 272 2-s2.0-77949772292 10.1038/nrg2764
129. Smith U., Gale E. A. M., Cancer and diabetes: are we ready for prime time? Diabetologia 2010 53 8 1541 1544 2-s2.0-77955511122 10.1007/s00125-010- 1815-8
130. Kim W. Y., Sharpless N. E., The Regulation of INK4/ARF in Cancer and Aging. Cell 2006 127 2 265 275 2-s2.0-33750030758 10.1016/j.cell.2006.10.003 (Pubitemid 44572384)
131. Krishnamurthy J., Ramsey M. R., Ligon K. L., Torrice C., Koh A., Bonner-Weir S., Sharpless N. E., p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006 443 7110 453 457 2-s2.0-33749187810 10.1038/nature05092 (Pubitemid 44477281)
132. Rane S. G., Dubus P., Mettus R. V., Galbreath E. J., Boden G., Reddy E. P., Barbacid M., Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β -islet cell hyperplasia. Nature Genetics 1999 22 1 44 54 2-s2.0-0032937751 10.1038/8751 (Pubitemid 29214803)
133. Holdt L. M., Teupser D., Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 196 206
134. Pasmant E., Laurendeau I., Héron D., Vidaud M., Vidaud D., Bièche I., Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Research 2007 67 8 3963 3969 2-s2.0-34248547495 10.1158/0008-5472.CAN-06-2004 (Pubitemid 46762186)
135. Visel A., Zhu Y., May D., Afzal V., Gong E., Attanasio C., Blow M. J., Cohen J. C., Rubin E. M., Pennacchio L. A., Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010 464 7287 409 412 2-s2.0-77949775636 10.1038/nature08801
136. Gudmundsson J., Sulem P., Steinthorsdottir V., Bergthorsson J. T., Thorleifsson G., Manolescu A., Rafnar T., Gudbjartsson D., Agnarsson B. A., Baker A., Sigurdsson A., Benediktsdottir K. R., Jakobsdottir M., Blondal T., Stacey S. N., Helgason A., Gunnarsdottir S., Olafsdottir A., Kristinsson K. T., Birgisdottir B., Ghosh S., Thorlacius S., Magnusdottir D., Stefansdottir G., Kristjansson K., Bagger Y., Wilensky R. L., Reilly M. P., Morris A. D., Kimber C. H., Adeyemo A., Chen Y., Zhou J., So W. Y., Tong P. C. Y., Ng M. C. Y., Hansen T., Andersen G., Borch-Johnsen K., Jorgensen T., Tres A., Fuertes F., Ruiz-Echarri M., Asin L., Saez B., Van Boven E., Klaver S., Swinkels D. W., Aben K. K., Graif T., Cashy J., Suarez B. K., Van Vierssen Trip O., Frigge M. L., Ober C., Hofker M. H., Wijmenga C., Christiansen C., Rader D. J., Palmer C. N. A., Rotimi C., Chan J. C. N., Pedersen O., Sigurdsson G., Benediktsson R., Jonsson E., Einarsson G. V., Mayordomo J. I., Catalona W. J., Kiemeney L. A., Barkardottir R. B., Gulcher J. R., Thorsteinsdottir U., Kong A., Stefansson K., Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nature Genetics 2007 39 8 977 983 2-s2.0-34547510624 10.1038/ng2062 (Pubitemid 47185170)
137. Thomas G., Jacobs K. B., Yeager M., Multiple loci identified in a genome-wide association study of prostate cancer. Nature Genetics 2008 40 310 315 (Pubitemid 351311773)
138. Ravassard P., Hazhouz Y., Pechberty S., A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. Journal of Clinical Investigation 2011 121 3589 3597
139. Seidler B., Schmidt A., Mayr U., Nakhai H., Schmid R. M., Schneider G., Saur D., A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors. Proceedings of the National Academy of Sciences of the United States of America 2008 105 29 10137 10142 2-s2.0-48249128709 10.1073/pnas.0800487105